| Diagnosis |
OS median (mo) |
Local Tumor Control Rate |
N° |
| CR |
PR |
SD |
PD |
(n-e) |
no FU |
death |
tot |
NSCLC
0-1.0
1.5-2.0
2.5-3.0
3.5-4.0 |
2
4(2-17)
5(2-17)
5(2-10) |
0
2(8%)
3(17%)
1(20%) |
0
5(21%)
2(11%)
1(20%) |
1(33%)
3(13%)
1(5%)
0 |
0
3(12%)
4(22%)
3(60%) |
2(66%)
4(16%)
0
0 |
0
3(12%)
3(17%)
0 |
0
4(16%)
5(28%)
0 |
3
24
18
5 |
SCLC
0-1.0
1.5-2.0
2.5-3.0
3.5-4.0 |
4 |
0
0
0
0 |
0
0
0
0 |
0
0
0
0 |
0
0
0
0 |
0
0
0
0 |
0
0
0
0 |
0
0
0
1(100%) |
0
0
0
1 |
Melanoma
0-1.0
1.5-2.0
2.5-3.0
3.5-4.0 |
3
5
11(6-14)
3.5(2-5) |
0
0
0
1(8%) |
0
0
1(33%)
3(23%) |
0
0
0
0 |
0
1(100%)
1(33%)
3(23%) |
0
0
0
5(38%) |
0
0
0
0 |
1(100%)
0
1(33%)
1(8%) |
1
1
3
13 |
RCC
0-1.0
1.5-2.0
2.5-3.0
3.5-4.0 |
4(3-5)
4.5(1-4) |
0
0
0
0 |
0
0
0
0 |
0
0
1 (50%)
0 |
0
1 (50%)
0
0 |
0
0
0
0 |
0
0
0
0 |
0
1 (50%)
1 (50%)
0 |
0
2
2
0 |
Breast
0-1.0
1.5-2.0
2.5-3.0
3.5-4.0 |
2.5(1-4)
8(4-12)
7(3-12) |
0
0
1(10%)
2(30%) |
0
1(17%)
2(20%)
0 |
0
1(17%)
2(20%)
3(50%) |
0
0
2(20%)
1(20%) |
0
0
1(10%)
0 |
1(100%)
0
2(20%)
0 |
0
4(66%)
0
0 |
1
6
10
6 |
GI
0-1.0
1.5-2.0
2.5-3.0
3.5-4.0 |
3.0 (2-4)
1
6
7(2-12) |
0
0
0
1 (50%) |
0
0
0
0 |
0
0
1 (100%)
1 (50%) |
0
1 (100%)
0
0 |
0
0
0
0 |
0
0
0
0 |
3 (100%)
0
0
0 |
3
1
1
2 |
Other
0-1.0
1.5-2.0
2.5-3.0
3.5-4.0 |
3
2(2-10)
4(5-7)
9(6-12) |
0
0
1(20%)
0 |
0
0
1(20%)
1(50%) |
1(50%)
3(75%)
0
0 |
0
1(25%)
2(40%)
0 |
0
0
0
0 |
1(50%)
0
0
0 |
0
0
1(20%)
1(50%) |
2
4
5
2 |
